Nuvig Therapeutics, Inc has appointed David J Woodhouse, PhD, as Chief Executive Officer. Along with his appointment, Nuvig is excited about his extensive experience and plans to advance NVG-2089 in multiple Phase 2 clinical trials.
Company Information
Company
Nuvig Therapeutics
Location
4200 Bohannon Dr
Menlo Park, California, United States
About
Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.
Fundz sees it the moment Nuvig Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Menlo ParkBiotechnologyHealth CareTherapeuticsresearch